A page that thinks you are someone else's customer
The weight-loss page opens with a heading that names a different company as the one whose treatment plan starts here, and it does so twice before any product appears. The weight-loss FAQ says most of that other company's members start on a compounded GLP-1. The footer invites clinicians to join that other company's provider team.
Zealthy is a seller reviewed on this site under a different legal entity. RoenRx's own privacy policy also names the company behind Zealthy among its partners, so the two are connected commercially, but they are not the same business and the pages do not say they are.
We record it as a defect rather than a theory. Whatever the arrangement is, a buyer reading the page that asks for a card is being told, in the site's own words, that they are somewhere else.
The cheapest number is not a price
The tile carrying the lowest figure sits under a heading reading With Insurance and lists four brand-name drugs. The FAQ explains it as a copay some members may pay depending on their plan, once a coordinator has worked the coverage.
That figure belongs to an insurer, not to this seller. We store it separately from the cash prices for exactly that reason: subtracting one from the other would print a saving no reader can act on.
The same page names the figure the copay is reducing, and the gap between the two is more than fiftyfold. Reading them as two prices for the same thing is the mistake the layout invites.
The cash lane, and the condition attached to it
A compounded semaglutide figure appears on the tile and again in the FAQ, and both times the condition is printed beside it: the rate holds when a three-month supply is bought. A compounded tirzepatide figure appears only in the FAQ.
Oddly, the compounded semaglutide tile also carries the With Insurance label, while the FAQ presents the same figure as the route for members who are not using insurance. The page contradicts itself about which regime the number belongs to, and we record both readings.
A membership exists and its first month is discounted. What it costs after that is never published, and the FAQ states that medication is not included in it.
Who is behind it
Its terms are unusually direct about the regulatory position, stating in one sentence that it offers compounded semaglutide and tirzepatide and that those are not FDA-approved. Few sellers here put it that plainly.
The corporate name appears in three forms across the site, differing in whether the word Health is present and where the commas fall, and a street address appears in the footer. The clinical work is attributed to two named professional entities.
No compounding pharmacy is named, no list of served states appears, and no prescribing clinician is named. It carries an FDA warning letter issued in June 2026 over false and misleading claims and misbranding, which is a disclosure and does not move its position here.
RoenRx's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $151/moas low as, and the condition is printed on the same tile — "when purchased quarterly"; its FAQ repeats it as "starting as low as $151 per month when purchasing a 3-month supply". ⛔ The tile also carries the label "With Insurance" although the FAQ presents this figure as the route for members who do not use insurance | September 2026source |
| Tirzepatide (compounded) | $216/moas low as, from the FAQ — "semaglutide may be available for as low as $151 per month, and tirzepatide for as low as $216 per month, depending on eligibility and treatment plan"; no tile on the priced page carries a tirzepatide figure | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 264 providers reviewed here are paid partners today; the other 260 are not. See how this works.
See RoenRx's current price →Good fit if
- Readers who want somebody to work their insurance coverage before they pay cash.
- Buyers who will read a tile's heading before reading its number.
- People who want the compounded regulatory position stated plainly in the terms.
Look elsewhere if
- Anyone who wants to know the total monthly outlay, given that the membership rate is unpublished.
- Buyers who need the compounding pharmacy named.
- Readers who need to know whether their state is served.
- Anyone unwilling to buy from a site whose own pages name a different company as the seller.
How this review was verified
- Read the homepage, the privacy policy, the terms of use, the priced weight-loss page and the weight-loss FAQ on 7 September 2026, comparing requested to effective URLs, with a nonsense path on the same host in the same run, which returned a 404.
- Quoted the three passages naming the other company from the extracted page text rather than describing them, and confirmed that company is a separate row here under a different legal entity.
- Kept the insurance-conditioned figure out of the price list entirely, and recorded the condition and the figure it reduces alongside it.
- Took the quarterly-purchase condition from the tile that carries the number, not from a separate page, and recorded the contradiction between the tile's label and the FAQ's explanation of the same figure.
- Screened the live FDA warning-letter datatable by entity name with a positive control returning exactly one row and a nonsense control returning none, then fetched the letter and confirmed its body names this seller's domain.